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Abstract: Paramyxovirinae, a subfamily of Paramyxoviridae, are negative strand RNA 
viruses comprised of many important human and animal pathogens, which share a high 
degree of genetic and structural homology. The accessory proteins expressed from the 
P/V/C gene are major factors in the pathogenicity of the viruses, because of their ability to 
abrogate various facets of type I interferon (IFN) induction and signaling. Most of the 
paramyxoviruses exhibit a commonality in their ability to antagonize innate immunity by 
blocking IFN induction and the Jak/STAT pathway. However, the manner in which the 
accessory proteins inhibit the pathway differs among viruses. Similarly, there are variations 
in the capability of the viruses to counteract intracellular detectors (RNA helicases, mda-5 
and RIG-I). Furthermore, a functional specificity in the antagonism of the IFN response 
has been reported, suggesting that specificity in the circumvention of innate immunity 
restricts viral host range. Available evidence indicates that paramyxoviruses employ 
specific strategies to antagonize the IFN response of their specific hosts, which is one of 
the major factors that determine viral pathogenicity and host range. 
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1. Introduction 
 
The interferon (IFN) system is the first line of defense against viral infection in mammals. This 
system is designed to block the spread of virus infection in the body. Detection of virus infection by 
intracellular receptors (sensors) results in activation of multiple pathways, leading to the production of 
IFN-/, which activates the Jak/STAT signaling pathway and stimulates transcription of a variety of 
antiviral genes in neighboring cells. Many of the pathogenic viruses, however, have evolved 
mechanisms to evade the IFN system by blocking IFN synthesis, the signaling pathway or both. In the 
case of paramyxoviruses, accessory proteins encoded by the P/V/C gene mediate antagonism of innate 
immunity. Mutant viruses unable to express the accessory proteins are attenuated in vivo, indicating 
the critical role of the accessory proteins in viral growth and pathogenicity. Although most of the 
paramyxoviruses are able to antagonize IFN activity, the mechanism and proteins responsible for the 
antagonism differs among the viruses. This minireview describes a variety of anti-innate activities 
mediated by accessory proteins of viruses belonging to the Paramyxoviridae subfamily, with the 
exception of henipavirus, which will be covered in a different section of this issue.  
2. General features of paramyxoviruses 
 
Family Paramyxoviridae, in the order Mononegavirales, is composed of a wide range of “classic” 
and “emerging” viruses of medical or veterinary significance. The family is categorized into two 
subfamilies, Paramyxovirinae and Pneumovirinae, according to several criteria, such as morphology, 
genomic organization, role of the encoded viral proteins and the sequence relationship between these 
proteins. Subfamily Paramxyxovirinae, which is the focus of this review, consists of five genera: 
Respirovirus,  Morbillivirus, Rubulavirus,  Avulavirus and Henipavirus. The well-studied viruses 
belonging to this subfamily include Sendai virus (SeV) and human parainfluenza virus types 1 and 3 
(hPIV1 and 3)(Respirovirus), parainfluenza virus 5 (PIV5, formerly SV5) and mumps virus 
(MuV)(Rubulavirus), measles virus (MeV)(Morbillivirus), Newcastle disease virus (NDV)(Avulavirus) 
and Hendra virus (HeV) and Nipah virus (NiV) (Henipavirus).  
Paramyxoviruses contain nonsegmented negative-strand RNA genomes. Their genomes are 15-
19 kB in length, and the genomes contain six to ten tandemly linked genes. Each gene is flanked by 
conserved transcriptional control sequences, which are linked by an intergenic sequence. The viral 
mRNAs are transcribed monocistronically, resulting in one protein being expressed from a single 
mRNA, except the P gene, as described below. Viral RNA is encapsidated with nucleocapsid (N) 
protein, which is associated with a polymerase complex composed of phospho- (P) and large (L) 
proteins. The virion contains a lipid bilayer envelope that is derived from the plasma membrane of the 
host cell. Inserted into the viral envelope are two surface glycoproteins responsible for virus 
attachment and membrane fusion. Residing between the envelope and the core is the viral matrix 
protein that is important in virion assembly and incorporation of nucleocapsid into progeny virions. 
Paramyxovirus replication takes place entirely in the cytoplasm, and progeny virions are formed at the 
plasma membrane of infected cells  [1].  Viruses 2009, 1                                       
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3. Paramyxovirus accessory proteins expressed from the P gene 
 
Most mRNAs of Paramyxovirinae are translated into one protein, with the exception of transcripts 
from the P gene, which express accessory proteins, in addition to the P protein. Non-rubulavirus 
Paramyxovirinae P proteins are expressed from a faithful transcript of the P gene, and all the viruses in 
this group express at least one accessory protein (Figure 1). They are expressed by two different 
strategies: one by RNA editing for V/W/D expression, and the other by overlapping open reading 
frame (ORF) for C expression. All the viruses of Paramyxovirinae encode a characteristic editing site 
in the P gene except hPIV1, and the number of inserted G residues, as well as the frequency of G 
nucleotide insertion is determined by sequences surrounding and within the editing site  [2-4]. All the 
V proteins are expressed from edited RNA containing a single G residue inserted at the editing site, 
except Rubulavirus that produces V protein from intact unedited mRNA, and edited RNA with 2 
inserted G residues translate the P protein. The V protein is a ~25- to ~30-kDa polypeptide that shares 
an N-terminal domain with the P protein but has a distinct C-terminal domain as a result of frame shift 
due to inserted G nucleotide(s). The C-terminal V-specific domain is highly conserved among related 
paramyxoviruses, with spaced histidine and cysteine residues forming a zinc-binding domain, and 
indeed binds two atoms of zinc molecules per V protein   [5-7]. Respiroviruses, Morbilliviruses, 
Avulaviruses and Henipaviruses express W/D proteins from mRNAs with two inserted G residues. The 
relative abundance of these proteins is low compared to the total P mRNA  [8]. The function of the W 
and D proteins is not clear, however, disruption of both V and D proteins of hPIV3 was shown to 
affect in vivo hPIV3 replication  [9], while disruption of the W protein had little effect on NDV growth 
in cultured cells  [10].  
In addition to RNA editing, Respiro-,  Morbilli- and Henipaviruses use alternative translation 
initiation codons to yield the C proteins (Figure 1). The number of expressed C proteins differs among 
paramyxoviruses, ranging from 1 to 4. SeV expresses a nested set of C proteins, C’, C, Y1 and Y2, that 
range in size from 175 to 215 residues. The ORFs are located upstream of the editing site and overlap 
the P ORF in the +1 frame. The initiation codons of C’, C, Y1, and Y2 are ACG
81, AUG
114, AUG
183 
and AUG
201, respectively. Translation of each of the C’, C, Y1, and Y2 ORFs is terminated at the same 
downstream stop codon; therefore, these proteins share a common C-terminal region. The hPIV1, 
which is highly homologous with SeV expresses only C’ and C. The hPIV3 and bPIV3 encode a single 
species of C protein composed of 199 and 201 residues, respectively. MeV also expresses a single 
species of C protein with 186 amino acids  [11]. HeV and NiV express C proteins composed of 166 
residues, and share 83% identity between the viruses  [12]. Viruses 2009, 1                                       
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Figure 1. Accessory proteins expressed from Paramyxovirinae. The V, W, and D mRNAs 
are generated by RNA editing, in which one or two G residues are inserted into the 
transcripts of the P gene at the editing site, except Rubulaviruses, which produce V from 
intact mRNA and P from edited mRNA. In addition to V/W/D proteins, Respirovirus, 
Morbillivirus and Henipavirus express C proteins from ORFs overlapping the amino-
terminal portion of the P ORF in the +1 frame.  
 
 
4. Functions of the accessory proteins expressed from the P/V/C gene 
C proteins are small basic polypeptides that contribute multiple functions to viral growth  [1]. The 
most prominent roles of C proteins are inhibition of intracellular Jak/STAT IFN signaling pathway and 
downregulation of viral RNA synthesis   [13,14]. Details of the anti-innate activities are described 
below. Earlier studies showed that SeV C protein binds L protein and inhibits viral mRNA 
synthesis  [15-17]. Also, SeV C proteins have been shown to make significant contributions to viral 
budding from the plasma membrane   [18], possibly by escorting ESCRT to the site of virion 
formation   [19], which is required for pinching off from budding plasma membrane patches. 
Recombinant SeV that does not express C proteins can be recovered, indicating that C proteins are 
categorically nonessential gene products  [20]. However, replication of this knockout virus was greatly 
impaired even in tissue culture cells, possibly due to the role of C protein in viral transcription, genome 
replication, and assembly. As expected, because of the functions of C protein in viral replication and 
anti-IFN activities, growth of recombinant SeV, hPIV1 and hPIV3 with disrupted C protein expression Viruses 2009, 1                                       
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are severely attenuated in vivo  [9,21,22]. In the case of MeV, C-deficient virus still grows well in 
certain culture cells but is less virulent in vivo  [23]. Changes in pathogenesis of C mutant viruses are 
likely to be related to the ability of C proteins to inhibit IFN responses, which is discussed in further 
detail below. 
V protein also plays a number of important roles in the virus replication cycle, as evidenced by 
many studies using recombinant viruses that have been engineered to disrupt expression of the whole 
V protein or its conserved cys-rich domain. In many cases, these mutant viruses grow well in tissue 
culture cell lines   [24-26], but are severely attenuated for growth in vivo or cleared rapidly from 
infected animals  [9,23,25,27], likely due to its capacity as an IFN antagonist.  
5. Innate immunity 
The innate immune response is a non-adaptive host defense that forms early barriers to infectious 
disease, and acts within minutes of infection to eradicate a pathogen or avoid the spread of infection 
until the threat can be eliminated by the adaptive immune response  [28]. Once the immune system has 
sensed viral infection, multiple signal transduction cascades are initiated resulting in expression of 
innate cytokines, including IFNs  [29]. IFNs are categorized as type I (IFN-), type II (IFN-) or 
type III (IFN-) based on sequence homology and the receptor complex used for signaling. Type I 
IFNs are secreted in direct response to virus infection and consist of the products of the IFN- 
multigene family, predominantly synthesized by hematopoietic cells and the product of the single IFN-
 gene, which is synthesized mainly by fibroblasts. The released IFNs bind to cell surface receptors 
and upregulate the expression of more than 300 cellular proteins. The expression of these proteins 
confers an antiviral state on the cells, providing the cells with an early defense against viral 
infections  [30]. 
5.1. Intracellular detection of viral infection by RIG-I/mda-5 and induction of IFN 
RNA helicases can recognize certain viral infection in cells by detecting viral nucleic acids 
generated in the cytoplasm of an infected cell. The two RNA helicases, retinoic acid inducible gene I 
(RIG-I) and melanoma differentiation-associated gene-5 (mda-5) have been shown to be important in 
detecting infection and inducing IFNs. These proteins contain a carboxyl-terminal DExD/H box RNA 
helicase domain, which recognizes dsRNA, and two amino-terminal caspase-recruiting domain 
(CARD)-like regions, which are responsible for recruiting downstream signaling molecules. The 
inhibition of RIG-I expression by siRNA limits IFN- induction after poly (I:C) treatment  [30,31]. 
The mda-5 shows similar properties to RIG-I, in that in response to their ligands, RIG-I and mda-5 
initiate a signaling cascade that results in the activation of transcription factors to promote the 
induction of IFN-/  [32,33]. It is thought that binding of viral RNA stimulates ATPase activity and 
triggers a major conformational change allowing dimerization, which reveals the CARD domains 
making the domains available to interact with the downstream adaptor protein 
Cardif/VISA/MAVS/IPS-1  [34-39]. This leads to activation of both IRF-3 and NF- which are 
required for transcriptional induction of the IFN- promoter. Upon translocation to the nucleus, these 
transcription factors bind to the IFN- promoter cooperatively with the c-jun/ATF-2 transcription 
factor to form the enhanceosome, which is required for optimal transcription of the IFN- gene. IFN- Viruses 2009, 1                                       
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production positively feeds back on the cell to upregulate the IRF-7 transcription factor and enhances 
further production of IFN.  
Extensive studies have been performed to determine whether RIG-I and mda-5 act as parallel 
sensors or have the ability to sense distinct virus-derived signals. It is becoming clear that viruses 
generate a variety of different pathogen associated molecular patterns (PAMPs), and mda-5 and RIG-I 
are differentially sensitive to activation by different viruses. Both mda-5 and RIG-I can be activated by 
synthetic double-strand RNA (dsRNA) poly (I:C). Studies using knockout mice showed that mda-5 
was much more important in regulating the response to poly (I:C) treatment than RIG-I   [40]. 
However, a recent study showed that length of the dsRNA influences whether IFN induction is 
dependent on mda-5 or RIG-I, with mda-5 being more important for induction by long dsRNA and 
RIG-I being more important for induction by short dsRNA  [41]. RIG-I and mda-5 also differ in their 
ability to recognize various types of RNA, suggesting that the two helicases recognize different 
structures within the RNA  [34]. Single-stranded RNA (ssRNA) and dsRNA molecules bearing a 5’ 
triphosphate induce IFN via RIG-I and not mda-5  [42,43]. Since most cellular RNAs are either capped 
or have a 5’  monophosphate, RNA with 5’ triphosphate is recognized as non-self. The ability to 
recognize different structures within ssRNA or dsRNA by the helicases explains the importance of 
mda-5 and RIG-I for IFN induction in response to various RNA virus infections.  
5.2. IFN signaling: Jak/STAT Pathway 
Binding of IFN to its cellular receptor triggers a signaling pathway and induces antiviral proteins. A 
vast array of cell types express cell surface receptors for type I IFNs. The type I IFN receptors are 
multimeric transmembrane glycoproteins whose extracellular domains bind IFN and whose 
cytoplasmic domains bind Jak, STAT and other signaling proteins  [44]. The receptor has two major 
subunits, IFNAR1, a 530 amino acid protein, and IFNAR2c, a 315 amino acid protein  [45]. Before 
activation, the IFNAR1 cytoplasmic tail is bound to tyrosine kinase 2 (Tyk2) and the IFNAR2 subunit 
associates with tyrosine kinase Jak1, STAT2 and is weakly associated with STAT1  [46-48]. Ligand 
binding dimerizes the receptor inducing a conformational change, resulting in the phosphorylation of 
tyrosine 466 on IFNAR1 by Tyk2. Phosphorylation of this tyrosine residue provides a strong docking 
site for STAT2. Tyk2 is then able to phosphorylate tyrosine 690 on STAT2, with phosphorylation of 
STAT1 performed by Jak1 on tyrosine 701. Phosphorylated STAT1 and STAT2 form a stable 
heterodimer, which creates a novel nuclear localization signal  [49]. In this way, the heterodimers are 
translocated into the nucleus and are retained until they are dephosphorylated  [50]. Once nuclear 
translocation of STAT1/STAT2 occurs, the complex binds to IRF-9 (p48) to produce the IFN 
stimulated gene factor 3 (ISGF3) heterotrimer. This trimeric complex then binds to the IFN-stimulated 
response element (ISRE), which acts as an enhancer on the 5’ regulatory regions of many of the IFN-
responsive gene promoters. 
6. Antagonism of innate immunity by the accessory proteins 
Like most other viruses, paramyxoviruses have evolved mechanisms that allow them to at least 
partially overcome the IFN response in order to establish a productive infection. They achieve this by 
reducing the production of IFN from infected cells, blocking IFN signaling or both. Interestingly, Viruses 2009, 1                                       
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accessory proteins that are responsible for anti-IFN activities vary among the viruses, as well as their 
strategies to achieve these tasks (Tables 1 and 2). 
6.1. Prevention of IFN production 
As discussed above, RNA helicases RIG-I and mda-5 detect viral RNAs and initiate a signaling 
cascade that results in the activation of transcription factors that promote IFN induction. Recent studies 
have unveiled the specific mechanism of how paramyxovirus accessory proteins inhibit IFN 
production. One of the best characterized accessory proteins for this function is PIV5 V protein. 
PIV5 V blocks activation of the IFN- promoter by transfected dsRNA, or following infection with a 
recombinant PIV5 encoding a mutant V protein lacking the cys-rich region   [51]. The V protein 
directly binds mda-5  [52] through the cys-rich region  [32], thereby inhibiting the activity of mda-
5   [34,52]. A recent study showed that upon dsRNA stimulation, mda-5 and RIG-I form homo-
oligomers through their helicase domains. Direct interaction of V protein with mda-5 prevents dsRNA 
binding and consequent self-association of mda-5  [34]. This ability to bind mda-5 through a conserved 
cys-rich region of V protein is shared among many paramyxoviruses. V proteins of many different 
paramyxoviruses, including PIV5, hPIV2, SeV, bPIV3, MuV, MeV and NDV, were examined and all 
of the V proteins were shown to interact with mda-5 and inhibit IFN induction  [32,52,53]. Analysis of 
the interaction interface revealed the mda-5 helicase C domain as necessary and sufficient for 
association with V proteins from PIV5, hPIV2, MeV and MuV  [54]. These V proteins, however, 
target mda-5, but not RIG-I. None of the V proteins inhibit IFN induction by RIG-I, except SeV, which 
showed a moderate inhibitory activity  [52]. It is not clear why V protein targets only mda-5, but not 
RIG-I. It is possible that this specificity is due to the specific pathogen-associated molecular patterns 
(PAMP) produced in infected cells. It might also be that the viruses, which only produce V protein and 
not C, may not generate RNAs that are detected by RIG-I, and therefore, it is not necessary to block 
RIG-I. Another possibility is that RIG-I may not generally be present in the types of cells that these 
viruses infect. Further studies will be necessary to clarify the PAMPs produced in paramyxovirus-
infected cells.  
In the case of the Respirovirus SeV, inhibition of IFN synthesis by V protein does not appear to be 
profound  in vivo, since the level of IFN in the infected mouse lung is not significantly different 
between infections with V(-) and wild-type (wt) SeV during the early period when their viral loads are 
similar  [55]. Instead, RIG-I has been suggested to play a major role in detection of SeV, bPIV3 and 
NDV infections  [31,33,40,53,56-58]. Infection with NDV or mutant SeV deficient in IFN antagonism 
because of mutations, induce IFN- in wt or mda5
-/- mouse embryonic fibroblasts (MEFs), but not in 
RIG-I
-/- MEFs  [40], suggesting that RIG-I is required for detection of NDV or SeV infection. The 
activation of RIG-I by SeV infection, as well as 5’-triphosphate RNA, is accompanied by the 
formation of RIG-I dimers  [39,59]. In addition to V protein, SeV and bPIV3 C proteins have been 
shown to modestly inhibit IFN- production irrespective of the species of signaling molecules used as 
an inducer  [53,56]. Independent expression of C or V inhibits the dsRNA- or NDV-induced activation 
of IRF-3 and NF-B, as well as the IFN- promoter  [60,61]. A study of SeV infection in MEFs 
showed that it is the C, but not V protein that is primarily responsible for antagonizing IFN induction, 
and that C acts by countering RIG-I, but not mda-5  [56].  Viruses 2009, 1                                       
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Table 1. Viral interference with IFN production. 
Virus               Accessory    Cellular       Mechanism                References 
                             protein         target 
Respirovirus      
SeV  V  mda-5  Direct binding to mda-5 blocks activation of mda-5  [32], [34], [52], [53], [61] 
  C  RIG-I  Inhibit IRF-3 and NF-kB transduction pathway  [53], [56], [61] 
hPIV1  C  ND  Inhibit IFN production stimulated by hPIV1 infection  [62] 
bPIV3  V  mda-5  Direct binding to mda-5 blocks activation of mda-5  [53] 
  C  ND  Suppress dsRNA-stimulated IFN production  [53] 
Morbillivirus 
MeV  V  mda-5  Direct binding to mda-5 blocks activation of mda-5  [34], [52] 
Rubulavirus 
PIV5  V  mda-5  Direct binding to mda-5 blocks activation of mda-5  [32], [34], [52] 
hPIV2  V  mda-5  Direct binding to mda-5 blocks activation of mda-5  [32], [52] 
MuV  V  mda-5  Direct binding to mda-5 blocks activation of mda-5  [32], [52] 
Avulavirus    
NDV  V  mda-5  Direct binding to mda-5 blocks activation of mda-5  [52] 
ND, not determined. 
 
Unlike other paramyxoviruses, hPIV1 does not express V protein. However, hPIV1 C protein has 
been found to inhibit the activation of IRF-3 and the production of IFN- in monkey and human 
cells  [62]. A mutant virus containing a single mutation at C protein F170S, which does not affect the 
P protein sequence, strongly activates IRF-3 and induces IFN- production, indicating hPIV1 C can 
circumvent IFN production stimulated by hPIV1 infection  [62]. It is not known yet, however, whether 
hPIV1 C targets RIG-I or mda-5. Morbillivirus MeV also expresses C protein, however, unlike its 
V protein, C protein possesses no activity to block the IFN production pathway per se  [63]. However, 
recombinant MeV lacking C protein expression strongly stimulates IFN production in spite of the 
production of V protein, possibly due to aberrant RNA synthesis in infected cells. Therefore, both V 
and C proteins, directly or indirectly, contribute to the suppression of IFN induction induced by 
MeV infection  [63,64].  
6.2. Various strategies to block the Jak/STAT pathway 
In addition to blocking IFN induction, paramyxovirus V and C proteins are known to block IFN 
signal transduction by targeting STAT proteins. STATs are essential components in the IFN signaling 
pathway that induce antiviral proteins in response to IFNs. While it is phenotypically similar in 
targeting and inhibiting STAT protein functions, the strategies of STAT-directed suppression by 
accessory proteins are diverse, as discussed below.  
One of the approaches used to inhibit IFN signaling by paramyxovirus accessory proteins is 
proteolytic degradation of STAT proteins. Rubulaviruses PIV5, MuV, hPIV2 and Avulavirus NDV are 
known to induce STAT degradation  [10,65-67]. It was first reported in a study of PIV5 that STAT1 Viruses 2009, 1                                       
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protein accumulation was dramatically reduced in cells infected with PIV5 or expressing PIV5 V  [65]. 
Chemical proteasome inhibitors prevent V-induced STAT degradation  [65,68]. The expression of the 
Rubulavirus V proteins was later demonstrated to induce polyubiquitylation of their target 
STATs  [66,69-72]. These viruses’ V proteins can assemble a ubiquitin ligase complex from cellular 
components, leading to the destruction of STAT proteins  [73]. Interestingly, the specificity of STAT 
protein targeting differs among the viruses; PIV5 and NDV V target STAT1 for polyubiquitylation and 
proteasomal degradation  [10,65], MuV V protein eliminates both STAT1  [71] and STAT3  [71,74], 
leaving STAT2 intact, and hPIV2 V protein targets STAT2  [66]. The specific STAT2 targeting by 
hPIV2, however, is more promiscuous compared to STAT1 degradation by PIV5   [75]. In fact, 
infection of BHK cells with hPIV2 led to the specific degradation of STAT1 and not STAT2  [76]. 
Both STAT1 and STAT2 are required to establish a degradation-permissive environment enabling 
PIV5 or hPIV2 to target their respective STAT protein. It has been shown that PIV5 and MuV can only 
target STAT1 in cells that express STAT2  [68,71,77], while hPIV2-mediated STAT2 degradation 
requires STAT1  [68]. PIV5 V does not bind to STAT1 directly, but it binds directly and independently 
to both DDB1, a component of a cellular SCF-like ubiquitin E3 ligase complex and STAT2. PIV5 V 
acts as an adaptor molecule linking DDB1 and STAT1/STAT2 heterodimers, which can ubiquitinate 
STAT1 in the presence of additional cellular proteins  [47,78]. V protein of Mapuera virus (MPRV), a 
newly emerging Rubulavirus, is also an effective inhibitor of IFN signaling, despite relatively low 
sequence similarities with other Rubulaviruses. However, MPRV V proteins do not degrade STATS or 
affect phosphorylation of STATs, but prevent IFN-induced STAT nuclear accumulation by interacting 
directly with both STAT1 and STAT2  [79]. Another member of Rubulavirus, hPIV4 expresses a V 
protein that contains a highly conserved cysteine-rich domain. However, hPIV4 V has no effects on 
STAT protein levels and IFN-induced signaling, even though it can associate with STAT1, STAT2, 
DDB1, and Cul4A  [80]. Therefore, hPIV4 is the only paramyxovirus analyzed to date that can’t evade 
IFN-induced antiviral responses. 
MeV V protein is distinct from V proteins of Rubulavirus, sharing only ~20% overall amino acid 
sequence identity. However, MeV V protein is known to be an efficient inhibitor of IFN signal 
transduction in both human and mouse cells, but acts via a distinct mechanism  [81]. Like MPRV, the 
MeV V protein does not degrade STATs, but prevents IFN-induced STAT nuclear accumulation by 
interacting with components of the IFN-/ signaling pathway in a multi-protein complex  [81,82]. 
STAT1 and Jak1 have been identified to be direct binding targets of MeV V protein, which results in 
inhibition of STAT1 phosphorylation by Jak1   [83]. Both N- and C-terminal domains of MeV V 
protein contribute to the inhibition of IFN-/ signaling. The binding sites of V to STAT1 and Jak1 
are distinct, since STAT1 does not compete with Jak1 for the interaction with V. Residues 110-120 of 
the V protein have been identified as a minimal STAT1 binding sequence  [84]. Mutation at Y110H in 
the N-terminal domain impairs STAT1 binding, but an additional mutation at C272R in the C-terminal 
domain is required for abrogation of IFN signaling  [83,85-87]. Furthermore, recent studies showed 
that the C-terminal domain of MeV V interacts directly with STAT2  [84,88]. This interaction with 
STAT2 is carried by the zinc-finger domain of the C-terminal region. The minimal STAT2 binding 
peptide contains the cysteine cluster that is a characteristic signature of the V proteins of 
Paramyxovirinae. These three interactions (STAT1, Jak1, and STAT2) allow MeV V to form a 
multiprotein complex with IFN-/ signaling components and block signaling downstream of the IFN-Viruses 2009, 1                                       
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/ receptor. In contrast to the major role of V protein, MeV C protein has only a minor effect on the 
inhibition of IFN signaling  [64,87,89].  
Table 2. Viral interference with IFN signaling. 
Virus               Accessory    Cellular           Mechanism                         References 
                             protein         target 
Respirovirus      
SeV  C  STAT1  Disordered phosphorylation of STAT  [13], [90-99] 
hPIV1  C  ND  Prevent nuclear translocation of STAT  [100], [101] 
hPIV3  C  ND  Block phosphorylation of STAT  [102] 
Morbillivirus 
MeV  V  STAT1, Jak1   Block phosphorylation of STAT1  [80-87] 
   STAT2 
Rubulavirus 
PIV5  V  STAT1  Proteasome mediated degradation of STAT1   [47], [65], [68], [70], [75], 
       [77],  [78] 
hPIV2  V  STAT2   Proteasome mediated degradation of STAT2    [66], [68], [70], [75], [76] 
MuV  V  STAT1, STAT3 Proteasome mediated degradation of STAT     [67], [69], [71], [72], [74] 
MPRV  V  STAT1,STAT2  Prevent nuclear translocation of STAT   [79] 
Avulavirus    
NDV  V  STAT1  Proteasome mediated degradation of STAT1    [9] 
ND, not determined. 
 
In the case of SeV, V protein has no effect on the IFN signaling pathway  [90]. Instead, C proteins 
have been shown to play a major role in blocking IFN signaling  [91-95]. SeV expresses a nested set of 
C proteins, but the shortest C protein, Y2 is fully capable of counteracting the signaling pathway  [13]. 
In fact, anti-IFN signaling activity of C protein does not require the N-terminal 98 amino acids of the 
protein  [96]. A broad range of activities of the C protein has been reported on the mechanism of 
Jak/STAT inhibition. Some studies showed that C proteins inhibit both STAT1 and STAT2 tyrosine 
phosphorylation   [92,97], and others showed that the C proteins cause prolonged tyrosine 
phosphorylation of STAT1, and impaired STAT1 serine phosphorylation  [98]. It was shown that the 
dephosphorylation process of pY-STAT1 was also impaired, suggesting that counteraction of IFN 
signaling by SeV C is caused by disordered phosphorylation and dephosphorylation of 
STAT1  [98,99]. Actually, SeV C protein physically binds STAT1, and prevents activation of both 
STAT1 and STAT2   [92,100]. A study using a series of mutant C proteins showed a definite 
correlation among STAT1-binding capacity and inhibitory activity for IFN signaling  [92]. Similar to 
SeV, the C  proteins of other Respiroviruses hPIV1 and hPIV3 inhibit activation of STAT 
proteins   [101-103]. Functional mechanisms of anti-IFN signaling of these viruses have not been 
determined, but a defect in STAT1 phosphorylation in hPIV3 C expressing cells has been 
reported  [103].  Viruses 2009, 1                                       
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7. Blocking apoptosis by accessory proteins 
When infected with a virus, the host attempts to suppress virus replication in infected cells and viral 
spread to neighboring cells by various means including induction of apoptosis. Because viruses are 
intracellular parasites, control over the cell’s death machinery is crucial for viral replication and 
pathogenicity  [104]. Apoptosis is a process in which cells activate intracellular death pathways to 
terminate themselves in a systematic way in response to a wide variety of stimuli. Apoptosis results 
from a collapse of cellular infrastructure through regulated internal proteolytic digestion, which leads 
to cytoskeletal disintegration, metabolic derangement and genomic fragmentation. Many viruses 
manipulate the apoptotic machinery to their advantage, and in the case of paramyxoviruses, accessory 
proteins expressed from the P/V/C gene play a role in blocking apoptotic cell death.  
Many paramyxoviruses lacking V or C protein expression show enhanced apoptosis in infected 
cells  [21,105-108]. One example is a recombinant PIV5 lacking the C-terminus of the V protein that 
induces apoptosis in tissue culture, in contrast to wt PIV5 that does not induce cytopathic effect (CPE). 
This apoptosis induction by the mutant virus can be prevented by expression of wt V, confirming the 
ability of V protein to prevent PIV5-induced apoptosis   [105]. Another study reported that PIV5 
containing mutations in
 the shared N termini of V and P protein (known as CPI–
 virus) accelerated 
viral gene expression and caused increased
 cell death with characteristics of apoptosis, suggesting that 
multiple regions in V are required for blocking apoptosis  [109,110].  
In the case of Respiroviruses, both hPIV1 and SeV C
 proteins have been shown to act as inhibitors 
of apoptosis through the characterization of C-deficient viruses. Early during
  infection  in vitro, 
rhPIV1-P(C–), which is deficient in C protein expression, replicated as efficiently
 as wt hPIV1, but its 
titer subsequently decreased
 coincident with the onset of extensive CPE
 not observed with wt hPIV1. 
The rhPIV1-P(C–) infection, but
 not wt hPIV1 infection, induced caspase 3 activation and nuclear
 
fragmentation in LLC-MK2 cells, identifying the hPIV1 C proteins
 as inhibitors of apoptosis  [21]. 
Similarly, SeV C
 deletion mutants have been shown to induce apoptosis in vitro, and longer C proteins 
(C’ and C) are more effective for the anti-apoptotic activity  [93,107].  
Infection with recombinant MeV lacking either V or C also causes more cell death than infection 
with the parental vaccine-equivalent virus   [89,111]. Infection with C-deficient MeV causes 
significantly less apoptosis in PKR-knockdown cells than in PKR-sufficient cells, suggesting a 
principal function of the MeV C protein is to antagonize the proapoptotic and antiviral activities of 
PKR  [108].  
8. Specificity of anti-IFN activities and its role in viral host range 
It is clear that anti-IFN and anti-apoptosis activities play a major role in viral pathogenicity to their 
specific hosts. These activities have also been suggested to contribute to host range restriction because 
of their specificity. It has been demonstrated that while PIV5 can enter murine cells and initiate viral 
protein synthesis, the infection is rapidly cleared by the endogenous innate system. PIV5 does not 
cause STAT1 degradation in murine cell culture  [112,113], however, expression of human STAT2 in 
mouse fibroblasts enabled PIV5 to effectively disrupt murine IFN signaling and to support specific 
degradation of the endogenous murine STAT1  [114]. These findings demonstrated a unique role for Viruses 2009, 1                                       
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STAT2 as a species-specific host range determinant and corroborated its importance as a cofactor for 
STAT1 targeting by PIV5. Like PIV5, NDV V protein antagonizes the avian IFN system via STAT1 
destabilization   [10]. Recombinant NDV deficient in V expression grows poorly in embryonated 
chicken eggs and chicken embryo fibroblasts (CEFs). Insertion of influenza virus NS1 gene restores 
impaired growth to wt levels in eggs and CEFs, indicating that NDV V and influenza NS1 are 
functionally interchangeable. However, in human cells, wt NDV grows poorly compared to   
NDV V(-)/NS1 virus, suggesting that the anti-IFN activity of NDV V protein is species specific  [106]. 
While the molecular basis has not yet been revealed, it is possible that, like PIV5, avian STAT2 might 
be involved in this specificity.  
Specificity of anti-innate activity was also suggested from studies using closely related 
Respiroviruses, SeV (a murine parainfluenza virus type 1) and hPIV1. A major difference in the anti-
IFN activity of these viruses is that SeV expresses both C proteins and a V protein, while hPIV1 
expresses only C proteins. A recombinant SeV, rSeVhP, whose P gene was replaced with that of 
hPIV1, has been rescued. This virus allows the determination of whether hPIV1 C proteins can 
substitute the function of SeV accessory C and V proteins. rSeVhP infection prevents nuclear 
translocation of STAT1 upon IFN stimulation, indicating that hPIV1 C protein can inhibit the 
Jak/STAT pathway in murine cells  [102]. Similarly, SeV C protein blocks the IFN signaling pathway 
in human cells  [101], suggesting no specificity in the inhibitory activity of the Jak/STAT pathway 
between these two viral C proteins. Infection of rSeVhP in murine cells, however, strongly activates 
IRF-3 and NF-B, resulting in an increased level of IFN- production compared with wt SeV. 
Insertion of SeV V, but not SeV C gene into rSeVhP partially restores the ability to suppress IFN 
induction, suggesting that V contributes to the suppression of IFN induction in SeV-infected murine 
cells  [102].  
9. Concluding remarks 
This minireview has illustrated a variety of functions and strategies of paramyxovirus accessory 
proteins in antagonizing host cell innate activities. Although this group of viruses has similar genome 
structure and replication patterns, their methods to circumvent the host cell innate activities vary 
between the viruses of this group. Most of the paramyxoviruses have been shown to antagonize both 
IFN induction and Jak/STAT signaling pathways by their various accessory proteins. In addition, a 
study on SeV suggests the accessory proteins can block IFN-independent antiviral activity directly 
induced in infected cells, the mechanism of which is not known. Much remains to be clarified about 
the complex interplay between host and viruses, especially, host or tissue specificity and its role in 
viral pathogenicity and host range. Elucidation of a detailed mechanism is essential for understanding 
viral pathogenicity and disease development, and will also provide key information that will lead to the 
development of a safe and effective attenuated live vaccine to clinically important paramyxoviruses.  
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